Latest Health News
Antimicrobial Resistance Predicted to Kill More Than Cancer by 2050
At Davos Frontiers Science House (Jan 19-23, 2026), experts warned antimicrobial resistance (AMR) will become a pandemic killing more than cancer by 2050, urging immediate global action. Speakers like Vanina Laurent Ledru and Peter Sands highlighted public mistrust and resource gaps fueling the 'silent pandemic'.
Cross-sector collaboration is essential to mitigate this guaranteed threat.
Gavi CEO Calls for Radical Reform of Global Health Institutions
Dr. Sania Nishtar urged merging operations of global health institutions to prioritize countries' needs, generating public goods, and aiding fragile contexts. In a Lancet viewpoint, she proposed a 'global health leap' to sustain gains amid crises.
Gavi's own reforms serve as a blueprint despite funding cuts.
Stanford Scientists Develop Cartilage Regrowth Therapy to Stop Arthritis
Stanford Medicine researchers discovered a treatment reversing cartilage loss in aging joints and preventing post-injury arthritis by blocking an aging-linked protein. The therapy restores shock-absorbing cartilage, offering hope for osteoarthritis patients.
Announced Jan 20, 2026.
Vagus Nerve Implant Provides Long-Term Relief for Treatment-Resistant Depression
Vagus nerve stimulation helped patients with long-standing depression improve and sustain benefits for at least two years after other treatments failed. Most participants experienced lasting mood improvements.
Study reported Jan 20, 2026.
Breakthrough in Growing Helper T Cells from Stem Cells for Cancer Therapy
Researchers solved a key challenge by reliably growing helper T cells from stem cells, enhancing immune-based cancer treatments. These cells coordinate stronger, longer immune attacks on tumors.
Advance announced Jan 20, 2026.
WHO Guide Promotes Child-Friendly Public Spaces for Health and Development
WHO, UNICEF, and UN-Habitat released a guide on Jan 21, 2026, urging cities to design safe, inclusive spaces amid shrinking play areas due to urbanization. Only 44% of urban residents access nearby public spaces, dropping lower in low-income countries.
Child-centered design advances health equity and climate resilience.
Northwestern Drug NU-9 Halts Alzheimer's in Preclinical Models
Northwestern scientists identified an Alzheimer's driver and showed experimental drug NU-9 stops disease progression before symptoms in animal models. The study highlights early intervention potential.
Findings from recent Feinberg School research.
UT Southwestern Biochemist Wins Japan Prize for Innate Immunity Discoveries
Zhijian 'James' Chen received the Japan Prize for identifying cGAS and MAVS, key proteins in innate immune responses to viruses and bacteria. His work elucidates how cells detect foreign DNA.
Announced for 2026 award.
Penn 'Armored' CAR T Therapy Succeeds in Resistant B-Cell Lymphomas
A next-generation armored CAR T cell therapy showed promise in patients resistant to prior treatments, including commercial CAR T, per NEJM study. Led by Jakub Svoboda and Carl June at Penn Medicine.
Named among top 2025 clinical advances.
Phase 3 Trial Starts for Delgocitinib Cream in Lichen Sclerosus
LEO Pharma initiated DELTA CARE 1 trial recruiting up to 652 adults to test delgocitinib cream's efficacy and safety for lichen sclerosus, a condition lacking approved U.S./EU treatments. Aims to improve quality of life for this burdensome disease.
Announced for 2026.
AI Tool Predicts Complications in Premature Newborns from Blood Samples
Stanford Medicine-led study developed AI to forecast medical trajectories of preemies using early blood samples. Enables personalized care predictions soon after birth.
Reported Jan 2026.
Regulators Fast-Track Gene Editing Therapy for Neonatal Liver Disease
iECURE's ECUR-506 received FDA Regenerative Medicine Advanced Therapy designation for neonatal liver disease via gene editing. Speeds development for this rare condition.
Recent regulatory milestone.